3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
92
Neoplasms
87
Lung Neoplasms
55
Prostatic Neoplasms
48
Colorectal Neoplasms
42
Carcinoma, Non-Small-Cell Lung
35
Pancreatic Neoplasms
24
Multiple Myeloma
24
Stomach Neoplasms
21
Hematologic Neoplasms
21
Carcinoma, Hepatocellular
19
Ovarian Neoplasms
18
Melanoma
17
Lymphoma
16
Leukemia, Myeloid, Acute
16
Esophageal Neoplasms
16
Brain Neoplasms
16
Urinary Bladder Neoplasms
13
Liver Neoplasms
13
Colonic Neoplasms
13
Uterine Cervical Neoplasms
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Neoplasm Metastasis
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Leukemia
12
Kidney Neoplasms
12
Head and Neck Neoplasms
12
Endometrial Neoplasms
12
Disease
12
Recurrence
11
Interventions
enzalutamide
1
apalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Metastatic Hormone-sensitive Prostate Cancer
×
30 days
×
Clear all
NCT05901649
2026-05-08
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
504 enrolled